Understanding Buprenorphine Formulations and Clinical Guidelines for Use
Understanding Buprenorphine Formulations and Clinical Guidelines for Use
Course Description
This 90-minute on-demand course will provide an overview of the various formulations of buprenorphine (including tablet, film, implantable, and injectable) for the treatment of opioid use disorder. Larissa Mooney, MD, and David Grelotti, MD, will discuss the differences in the delivery of each formulation as well as provide their clinical practice experiences with each formulation. A consumer will discuss finding the right formulation for his treatment.
Launch Date: April 9, 2020
At the conclusion of the on-demand course, participants will be able to:
- Review the three (3) waves of the opioid epidemic.
- Consider the three (3) routes of administration for the various formulations of buprenorphine.
- Describe the mechanism of action of buprenorphine.
- Determine two (2) potential benefits of buprenorphine as a medication for opioid use disorder.
Instructions for Continuing Education Credits
How to receive a CE/CME certificate:
For Continuing Medical Education (CME) for physicians, physician assistants, nurses, and nurse practitioners only, you will receive a link to complete the course evaluation for CME after watching the video for this course, and you will receive your CE certificate via email within six to eight weeks.
If you have any CME-related questions, please contact Gloria Miele at gmiele@mednet.ucla.edu.
For other disciplines, you must pass the final test with a minimum of 80% correct. Once you pass the final test, you will be given links to complete a follow-up course evaluation. Choose the link that corresponds with the type of license you have. The link will take you to a course evaluation. Once you submit this required course evaluation, you will receive your CE certificate via email within six to eight weeks.
If you have any CE-related questions, please contact Darren Manley at dmanley@mednet.ucla.edu.
CME Statements:
Please view the linked CME Learner Handout for more information about how to obtain CME credit.
The training course meets the qualifications for the provision of one and one-half (1.5) continuing medical education credits/contact hours (CMEs/CEHs).
UCLA Integrated Substance Abuse Programs (ISAP) is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.
UCLA Integrated Substance Abuse Programs (ISAP) designates this on-demand course for a maximum of one and one-half (1.5) AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 CreditsTM (rn.ca.gov). Nurses will receive a Certificate of Participation following this activity that may be used for license renewal.
Continuing medical education will be awarded within 6-8 weeks following completion of the on-demand course.
Continuing Education:
The training course meets the qualifications for the provision of one and one-half (1.5) continuing education credits/contact hours (CEs/CEHs). UCLA Integrated Substance Abuse Programs (ISAP) is approved by the American Psychological Association to sponsor continuing education for psychologists. UCLA ISAP maintains responsibility for this program and its content
UCLA ISAP is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or LEPs (Provider #64812). UCLA ISAP maintains responsibility for this program/course and its content. Course meets the qualifications for one and one-half (1.5) hours of continuing education credit for LMFTs, LCSWs, LPCCs, and LEPs as required by the California Board of Behavioral Sciences. UCLA ISAP is also an approved provider of continuing education for RADTs I/II, CADCs-CASs, CADCs I/II, CADCs-CSs, and LAADCs (CCAPP, #2N-21-339-1225), CATCs (ACCBC/CAADE, #CP40 872 C 0825), and CAODCs (CADTP, #151).
CE credit will be awarded at the conclusion of the training. Upon completing the final module, you must pass the final test with a minimum of 80% correct. Once you pass the final test, it will display a link to complete a course evaluation and submit the required information for your CE certificate. Upon completing this required course evaluation, you will receive your CE certificate via email within six to eight weeks.
If you have any CE-related questions, please contact Darren Manley at dmanley@mednet.ucla.edu.
Estimated time to complete the course:
Cost: Free
Disclosure statements:
None of the presenters, planners, or others in control of content for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients, except:
Larissa Mooney, MD – Advisory Board, Alkermes
David Grelotti, MD – Consulting Fees, Greenwich Biosciences, Inc
Trainers:
Larissa Mooney, MD
UCLA Integrated Substance Abuse Programs (ISAP) – Associate Professor of Psychiatry
David Grelotti, MD
UC San Diego’s Owen Clinic – Director of Mental Health and Substance Use Treatment Services
Recommended Audience:
This on-demand course is recommended for medical, behavioral health, and substance use disorder clinicians and administrative staff who are involved in providing multidisciplinary care to persons with opioid, stimulant, and other substance use disorders, including, but not limited to:
- Physicians
- Physician Assistants
- Nurse Practitioners
- Registered Nurses and LVNs
- Psychologists
- Marriage and Family Therapists
- Social Workers
- Alcohol and Other Drug and Mental Health Counselors
- Case Managers
- Medical Assistants
Instructions for Requesting Accommodations for Disability:
If you need a disability-related reasonable accommodation/alternative format for this event, please contact Darren Manley at dmanley@mednet.ucla.edu.
Instructions for Filing a Grievance Concerning UCLA ISAP’s Continuing Education Program:
Please contact Dr. Thomas E. Freese, CE Program Administrator, in writing:(UCLA ISAP, 10911 Weyburn Ave, Suite 200, Los Angeles, CA 90024) or by phone (310-267-5397). Alternately, you may contact Dr. Gloria Miele or Dr. James Peck, ISAP-affiliated doctoral-level psychologists responsible for program planning for the ISAP CE Program. Drs. Miele and Peck can be reached in writing at: 10911 Weyburn Ave, Suite 200, Los Angeles, CA 90024 or by phone at: 310-267-5888 (Miele) or 310-267-5346 (Peck).
